The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial

類似資料

• Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation
  著者:: Oscier, David, 等
  出版事項: (2010)
• The long‐term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 years
  著者:: Else, Monica, 等
  出版事項: (2015)
• The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trial
  著者:: Else, Monica, 等
  出版事項: (2021)
• The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry
  著者:: Matutes, E, 等
  出版事項: (2013)
• Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial
  著者:: Blakemore, Stuart J., 等
  出版事項: (2020)